Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02754544 · ClinicalTrials.gov registry record · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
A NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02754544 is a NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 75 participants, below the 86-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02754544, a NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies how well electrocorticography works in mapping functional brain areas during surgery in patients with brain tumors. Using a larger than the standard mapping grid currently used during brain tumor surgery or a high-definition grid for electrocorticogram brain mapping may help doctors to better identify which areas of the brain are active during specific limb movement and speech during surgery in patients with brain tumors.
Conditions Studied
Interventions
- PROCEDURE Direct Electrocortical Stimulation
- OTHER Electrocorticography
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-07-22 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02754544
The ClinicalTrials.gov registry entry for NCT02754544 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (13% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Metastatic Malignant Neoplasm in the Brain appearing as the primary indexed condition, and to 2 interventions - of which Direct Electrocortical Stimulation is the first listed.
NCT02754544 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02754544 about?
NCT02754544 is a clinical study titled "Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors". This pilot clinical trial studies how well electrocorticography works in mapping functional brain areas during surgery in patients with brain tumors. Using a larger than the standard mapping grid currently used during brain tumor surgery or a high-definition grid for electrocorticogram brain mapping...
What is the current status of trial NCT02754544?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2016-07-22. Estimated completion is 2028-01-01.
What conditions does trial NCT02754544 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Brain, Brain Neoplasm, Recurrent Brain Neoplasm.
What interventions are being tested in trial NCT02754544?
The interventions under investigation include: Direct Electrocortical Stimulation (PROCEDURE), Electrocorticography (OTHER).
Who is sponsoring clinical trial NCT02754544?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02754544 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
RECRUITING · NA
-
nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex
ACTIVE NOT RECRUITING · NA
-
Mind-Body Intervention in Glioma Couples
ACTIVE NOT RECRUITING · NA
-
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.